THURSDAY, May 11, 2023 (HealthDay News) — A medication to treat agitation in Alzheimer’s patients now has approval from the U.S. Food and Drug Administration. The FDA gave supplemental approval to Otsuka Pharmaceutical Company Ltd., and Lundbeck Inc. for Rexulti (brexpiprazole) oral tablets on Thursday. Rexulti is the first FDA-approvedContinue Reading

THURSDAY, May 11, 2023 (HealthDay News) — Medications that treat opioid addiction and prevent overdose deaths are drastically under-prescribed in the United States, particularly for Black patients, a new study has found. Disabled people on Medicare are not likely to be prescribed either buprenorphine – the best medication for treatingContinue Reading

FRIDAY, May 5, 2023 (HealthDay News) — Researchers think they’ve figured out why the COVID vaccine causes heart inflammation in an extremely small number of teenage boys — and what might be done to avoid it. The second dose of COVID vaccine appears to promote a severe inflammatory response inContinue Reading